Literature DB >> 20359515

Effects of Tau on the activity of triose phosphate isomerase (TPI) in brain cells.

Seung-Ah Park1, Hye Won Park, Nam-Hee Kim, Yoon-Ha Kim, Min-Jeong Kwak, Jun-Seop Shin, Chan-Wha Kim.   

Abstract

Tau is a main component of the aberrant paired helical filaments (PHF) found in Alzheimer's disease (AD). It has also been reported to enhance oxidative stress, which is a major factor in the pathogenesis of neurodegenerative diseases. However, protective functions of Tau have recently been reported, including antagonizing apoptosis, in addition to its role in stabilizing microtubules. In this study, the interaction between Tau and triose phosphate isomerase (TPI) in a normal, nondisease state as well as in a neurodegeneration state was examined and demonstrated for the first time. More importantly, we also showed that Tau protects TPI against oxidative damage. An oxidative stress-induced decrease in the activity of TPI was attenuated in Tau-overexpressing cells, indicating that Tau protects TPI against oxidative damage. By contrast, the activity of TPI was decreased in Tau-transgenic (Tg) mice compared to non-Tg (NTg) mice even though protein levels were not changed in both groups. Some TPIs were found on the PHF in Tg mice, which explains the decrease in the activity of TPI. Taken together, we concluded that while Tau binds and protects TPI in normal cells, and conversely, the formation of PHF induced by Tau phosphorylation trap some TPI and trigger the functional loss of TPI in the development of neurodegenerative diseases. Our results provide new insights into understanding the in-depth involvement of Tau in the development of neurodegenerative disorders. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359515     DOI: 10.1016/j.neuint.2010.03.014

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  5 in total

1.  Nuclear translocation of anamorsin during drug-induced dopaminergic neurodegeneration in culture and in rat brain.

Authors:  Kyung-Ah Park; Nuri Yun; Dong-Ik Shin; So Yoen Choi; Hyun Kim; Won-Ki Kim; Yuzuru Kanakura; Hirohiko Shibayama; Young J Oh
Journal:  J Neural Transm (Vienna)       Date:  2010-10-06       Impact factor: 3.575

2.  Improvement of spatial memory disorder and hippocampal damage by exposure to electromagnetic fields in an Alzheimer's disease rat model.

Authors:  Xiao Liu; Hongyan Zuo; Dewen Wang; Ruiyun Peng; Tao Song; Shuiming Wang; Xinping Xu; Yabing Gao; Yang Li; Shaoxia Wang; Lifeng Wang; Li Zhao
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

Review 3.  Mitochondrial dysfunction and oxidative stress in aging and cancer.

Authors:  Anna V Kudryavtseva; George S Krasnov; Alexey A Dmitriev; Boris Y Alekseev; Olga L Kardymon; Asiya F Sadritdinova; Maria S Fedorova; Anatoly V Pokrovsky; Nataliya V Melnikova; Andrey D Kaprin; Alexey A Moskalev; Anastasiya V Snezhkina
Journal:  Oncotarget       Date:  2016-07-19

4.  Sex-Specific Effects of Chronic Creatine Supplementation on Hippocampal-Mediated Spatial Cognition in the 3xTg Mouse Model of Alzheimer's Disease.

Authors:  Wanda M Snow; Chris Cadonic; Claudia Cortes-Perez; Aida Adlimoghaddam; Subir K Roy Chowdhury; Ella Thomson; Adama Anozie; Michael J Bernstein; Kathleen Gough; Paul Fernyhough; Miyoung Suh; Benedict C Albensi
Journal:  Nutrients       Date:  2020-11-23       Impact factor: 5.717

5.  Aging, Alzheimer's Disease and Dysfunctional Glycolysis; Similar Effects of Too Much and Too Little.

Authors:  Alan R Hipkiss
Journal:  Aging Dis       Date:  2019-12-01       Impact factor: 6.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.